Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Mustang Bio Inc a clinicalstage biopharmaceutical company focused on translating todays medical breakthroughs in cell and gene therapies into potential cures for difficulttotreat cancers
Merck known as MSD outside of the United States and Canada today announced that the European Commission has approved KEYTRUDA Mercks antiPD therapy in combination
Zai Lab Limited partner Novocure today announced the phase METIS clinical trial met its primary endpoint demonstrating a statistically significant improvement
FSD Pharma Inc a biopharmaceutical company dedicated to building a portfolio of
Syndax Pharmaceuticals a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies today announced that the US Food
Teva UK Limited and Closed Loop Medicine Ltd have announced a strategic partnership to advance the development of personalised medicines
Serina Therapeutics a clinicalstage biotechnology company developing a pipeline of therapies for the treatment of Parkinsons Disease and other neurological diseases today announced the closing of its previously
FUJIFILM Diosynth Biotechnologies a worldleading contract development and manufacturing organization for biologics vaccines advanced therapies
Apogee Therapeutics Inc a clinicalstage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis COPD asthma and other inflammatory and immunology
Novo Nordisk and Cardior Pharmaceuticals today announced that Novo Nordisk has agreed to acquire Cardior for up to billion Euros including an upfront payment and additional payments if certain development
